Comparison of the Actions of Acebutolol, Practolol and Propranolol on Calcium Transport by Heart Microsomes and Mitochondria

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1976 Jun 1

PMID 132977

Citations 8

Authors

N S Dhalla

S L Lee

Affiliations

Soon will be listed here.

Abstract

1 The effects of acebutolol, practolol and propranolol (0,5-3 mM) on calcium uptake, calcium binding and ATPase activities of the rabbit and rat heart microsomal and mitochondrial fractions were investigated. 2 Dose-response and time course experiments revealed that propranolol greatly inhibited microsomal and mitochondrial calcium uptake whereas both acebutolol and practolol showed slight depressant effects. 3 The ATPase activities of microsomal and mitochondrial fractions were decreased by acebutolol, practolol and propranolol; however, the latter agent was more effective than the other two. 4 The inhibitory effects of acebutolol, practolol and propranolol on mitochondria and microsomes were not antagonized by adrenaline. 5 Propranolol decreased calcium binding by the microsomal fraction only, whereas acebutolol and practolol had no effect on microsomal or mitochondrial calcium binding. 6 The sensitivity of the rabbit heart subcellular fractions to the beta-adrenoceptor blocking drugs was similar to that of the rat heart; however, the calcium uptake and ATPase activities of microsomes were more sensitive to propranolol than mitochondria in both species. 7 Perfusion of rat hearts with 0.2-1 mM propranolol decreased contractile force, and microsomal and mitochondrial fractions obtained from these hearts accummulated less calcium in comparison to the control. On the other hand, acebutolol and practolol (0.2-1nM) had no appreciable effects on contractile force or subcellular fractions under similar conditions. 8 The negative inotropic effect of propranolol may partly be due to its inhibitory actions on calcium transport by subcellular organelles of the myocardium; the depressant action of propranolol on calcium transport is unlikely to be due to its beta-adrenoceptor blocking property.

Citing Articles

Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Perez D Int J Mol Sci. 2021; 22(11).

PMID: 34071350 PMC: 8198887. DOI: 10.3390/ijms22115783.

Alterations in the heart sarcolemmal Ca2+ transport activity by some beta-adrenergic antagonists.

Dzurba A, Ganguly P, Guerin A, Dhalla N Basic Res Cardiol. 1984; 79(6):620-6.

PMID: 6152393 DOI: 10.1007/BF01908380.

Stimulant and depressant effects of beta-adrenoceptor blocking agents on isolated heart muscle. A positive inotropic effect not mediated through andrenoceptors.

Kaumann A, BLINKS J Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(3):205-18.

PMID: 6104791 DOI: 10.1007/BF00569401.

Effects of (+)-propranolol on intracellular mechanisms of contraction in striated muscle of the rabbit.

Su J, Malencik D Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(2-3):194-201.

PMID: 4088321 DOI: 10.1007/BF00634238.

Interaction of some antiarrhythmic drugs with the heart sarcolemmal Na+-Ca2+ exchange system.

Eyolfson D, Dhalla N Basic Res Cardiol. 1989; 84(4):414-20.

PMID: 2818441 DOI: 10.1007/BF02650876.

References

TAUSSKY H, SHORR E . A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem. 1953; 202(2):675-85. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Basil B, Jordan R, Loveless A, Maxwell D . Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Br J Pharmacol. 1973; 48(2):198-211. PMC: 1776183. DOI: 10.1111/j.1476-5381.1973.tb06906.x. View

Pang D, BRIGGS F . Mechanism of propranolol inhibition of the cardiac sarcotubule-gamma-AT32P reaction. Biochem Pharmacol. 1973; 22(11):1301-8. DOI: 10.1016/0006-2952(73)90304-3. View

Dhalla N, Sulakhe P, Fedelesova M, Yates J . Molecular abnormalities in cardiomyopathy. Adv Cardiol. 1974; 13:282-300. DOI: 10.1159/000395542. View

Sulakhe P, Dhalia N . Excitation-contraction coupling in heart. VII. Calcium accumulation in subcellular particles in congestive heart failure. J Clin Invest. 1971; 50(5):1019-27. PMC: 292024. DOI: 10.1172/JCI106573. View

NAYLER W . The effect of pronethalol and propranolol on lipid-facilitated transport of calcium ions. J Pharmacol Exp Ther. 1966; 153(3):479-84. View

SCALES B, MCINTOSH D . Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF). J Pharmacol Exp Ther. 1968; 160(2):261-7. View

Noack E, GREEFF K . The influence of some cardioactive drugs on the energy-dependent uptake of calcium, potassium and adenine nucleotides by mitchondria. J Mol Cell Cardiol. 1971; 2(2):145-59. DOI: 10.1016/0022-2828(71)90067-8. View

10.

Coleman A, Leary W . Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol. Curr Ther Res Clin Exp. 1972; 14(10):673-8. View

11.

Katz A, Repke D, Tada M, Corkedale S . Propranolol-induced inhibition of cardiac microsomal calcium-uptake, calcium-binding, and epinephrine-stimulated adenylate cyclase. Cardiovasc Res. 1974; 8(4):541-9. DOI: 10.1093/cvr/8.4.541. View

12.

Lameijer W, van Zwieten P . Comparison between the uptake of propranolol and its influence on the relative refractory period and on contractile force. Arch Int Pharmacodyn Ther. 1974; 210(2):306-20. View

13.

Basil B, Jordan R, Loveless A, Maxwell D . A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol. Br J Pharmacol. 1974; 50(3):323-33. PMC: 1776679. DOI: 10.1111/j.1476-5381.1974.tb09607.x. View

14.

Solaro R, Gertz E, BRIGGS F . Sucrose antagonism of drug and temperature effects on cardiac sarcoplasmic reticulum. Biochim Biophys Acta. 1972; 255(3):751-6. DOI: 10.1016/0005-2736(72)90388-4. View

15.

Dhalla N, Yates J, Walz D, McDonald V, Olson R . Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol. 1972; 50(4):333-45. DOI: 10.1139/y72-050. View

16.

HARIGAYA S, Schwartz A . Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Membrane vesicles (relaxing system) and mitochondria. Circ Res. 1969; 25(6):781-94. DOI: 10.1161/01.res.25.6.781. View

17.

Hess M, BRIGGS F, Shinebourne E, Hamer J . Effect of adrenergic blocking agents on the calcium pump of the fragmented cardiac sarcoplasmic reticulum. Nature. 1968; 220(5162):79-80. DOI: 10.1038/220079a0. View

18.

Shinebourne E, White R, Hamer J . A qualitative distinction between the beta-receptor-blocking and local anesthetic actions of antiarrhythmic agents. Circ Res. 1969; 24(6):835-41. DOI: 10.1161/01.res.24.6.835. View

19.

DOHADWALLA A, FREEDBERG A, VAUGHAN WILLIAMS E . The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias. Br J Pharmacol. 1969; 36(2):257-67. PMC: 1703374. DOI: 10.1111/j.1476-5381.1969.tb09503.x. View